Stroke-induced microRNAs: The potential therapeutic role for stroke (Review)

Wu,Ping; Zuo,Xialin; Ji,Aimin

doi:10.3892/etm.2012.452

Stroke-induced microRNAs: The potential therapeutic role for stroke (Review)

Authors:
- Ping Wu
- Xialin Zuo
- Aimin Ji
View Affiliations

Affiliations: Center of New Drug Research and Development, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P.R. China
Published online on: January 13, 2012 https://doi.org/10.3892/etm.2012.452
Pages: 571-576

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Stroke is one of the leading causes of death and disability worldwide. In past decades, researchers have studied the physiopathology and biochemistry of stroke, but knowledge of the molecular mechanisms underlying this disease remains at an early stage. To date, only recombinant tissue plasminogen activator (rtPA) has been approved by the USA FDA for acute ischemic stroke. However, as the limiting therapy time window is 4.5 h after stroke onset and patients must meet the applicable conditions, a small number of patients benefit from this therapy. Therefore, the research and development of new drugs for stroke are a big challenge for scientists. MicroRNAs (miRNAs) are short (20-23 nucleotides) single-stranded non-coding RNAs. The seed sequences at positions 2-7 from the 5' end which are partially or complementary to one or more mRNAs inhibit or degrade target mRNAs, thus playing an important role in the post-transcriptional regulation of gene expression. Disregulated miRNAs have revealed their complex role in pathophysiological processes, and have also shown their potential role in disease diagnosis, and use as drug targets in neurodegenerative diseases and cancer. Recently, studies have found aberrantly expressed miRNAs in stroke; however, the implication of deregulated miRNA expression in stroke remains largely unknown. This review briefly summarizes recent studies concerning miRNA expression in stroke in vivo and in vitro, focuses on aberrant miRNA expression, as well as discusses their potential therapeutic role for stroke.

View Figures

View References

1.	Beal CC: Gender and stroke symptoms: a review of the current literature. J Neurosci Nurs. 42:80–87. 2010. View Article : Google Scholar : PubMed/NCBI
2.	Mocellin S, Pasquali S and Pilati P: Oncomirs: from tumor biology to molecularly targeted anticancer strategies. Mini Rev Med Chem. 9:70–80. 2009. View Article : Google Scholar : PubMed/NCBI
3.	Johnnidis JB, Harris MH, Wheeler RT, et al: Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 451:1125–1129. 2008. View Article : Google Scholar : PubMed/NCBI
4.	Merkerova M, Belickova M and Bruchova H: Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol. 81:304–310. 2008. View Article : Google Scholar : PubMed/NCBI
5.	Aumiller V and Förstemann K: Roles of microRNAs beyond development – metabolism and neural plasticity. Biochim Biophys Acta. 1779:692–696. 2008.
6.	Carissimi C, Fulci V and Macino G: MicroRNAs: novel regulators of immunity. Autoimmun Rev. 8:520–524. 2009. View Article : Google Scholar : PubMed/NCBI
7.	Bushati N and Cohen SM: MicroRNAs in neurodegeneration. Curr Opin Neurobiol. 18:292–296. 2008. View Article : Google Scholar
8.	Lawrie CH, Soneji S, Marafioti T, et al: MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer. 121:1156–1161. 2007. View Article : Google Scholar : PubMed/NCBI
9.	Nelson PT, Wang WX and Rajeev BW: MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol. 18:130–138. 2008. View Article : Google Scholar : PubMed/NCBI
10.	Schratt G: microRNAs at the synapse. Nat Rev Neurosci. 10:842–849. 2009. View Article : Google Scholar
11.	Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E and Ambros V: Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 5:R132004. View Article : Google Scholar
12.	Mishima T, Mizuguchi Y, Kawahigashi Y and Takizawa T and Takizawa T: RT-PCR-based analysis of microRNA (miR-1 and -124) expression in mouse CNS. Brain Res. 1131:37–43. 2007. View Article : Google Scholar : PubMed/NCBI
13.	Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W and Tuschl T: Identification of tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. 2002. View Article : Google Scholar : PubMed/NCBI
14.	Yu JY, Chung KH, Deo M, Thompson RC and Turner DL: MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp Cell Res. 314:2618–2633. 2008. View Article : Google Scholar : PubMed/NCBI
15.	Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M and Greenberg ME: A brain-specific microRNA regulates dendritic spine development. Nature. 439:283–289. 2006. View Article : Google Scholar : PubMed/NCBI
16.	Gaughwin P, Ciesla M, Yang H, Lim B and Brundin P: Stage-specific modulation of cortical neuronal development by Mmu-miR-134. Cereb Cortex. 21:1857–1869. 2011. View Article : Google Scholar : PubMed/NCBI
17.	Vo N, Klein ME, Varlamova O, et al: A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci USA. 102:16426–16431. 2005. View Article : Google Scholar : PubMed/NCBI
18.	Wayman GA, Davare M, Ando H, et al: An activity-regulated microRNA controls dendritic plasticity by downregulating p250GAP. Proc Natl Acad Sci USA. 105:9093–9098. 2008. View Article : Google Scholar : PubMed/NCBI
19.	O’Neill LA: Boosting the brain’s ability to block inflammation via microRNA-132. Immunity. 31:854–855. 2009.
20.	Jeyaseelan K, Lim KY and Armugam A: MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke. 39:959–966. 2008. View Article : Google Scholar : PubMed/NCBI
21.	Dharap A, Bowen K, Place R, Li LC and Vemuganti R: Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab. 29:675–687. 2009. View Article : Google Scholar : PubMed/NCBI
22.	Tan KS, Armugam A, Sepramaniam S, et al: Expression profile of microRNAs in young stroke patients. PLoS One. 4:e76892009. View Article : Google Scholar : PubMed/NCBI
23.	Liu DZ, Tian Y, Ander BP, et al: Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab. 30:92–101. 2010. View Article : Google Scholar : PubMed/NCBI
24.	Lusardi TA, Farr CD, Faulkner CL, et al: Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J Cereb Blood Flow Metab. 30:744–756. 2010. View Article : Google Scholar : PubMed/NCBI
25.	Kim JB, Piao CS, Lee KW, et al: Delayed genomic responses to transient middle cerebral artery occlusion in the rat. J Neurochem. 89:1271–1282. 2004. View Article : Google Scholar : PubMed/NCBI
26.	Lee ST, Chu K, Jung KH, et al: MicroRNAs induced during ischemic preconditioning. Stroke. 41:1646–1651. 2010. View Article : Google Scholar : PubMed/NCBI
27.	Dharap A and Vemuganti R: Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J Neurochem. 113:1685–1691. 2010.PubMed/NCBI
28.	Boissonneault V, Plante I, Rivest S and Provost P: MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem. 284:1971–1981. 2009. View Article : Google Scholar : PubMed/NCBI
29.	Stenzel-Poore MP, Stevens SL, Xiong Z, et al: Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet. 362:1028–1037. 2003. View Article : Google Scholar
30.	Yin KJ, Deng Z, Huang H, et al: miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis. 38:17–26. 2010. View Article : Google Scholar : PubMed/NCBI
31.	Yin KJ, Deng Z, Hamblin M, et al: Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J Neurosci. 30:6398–6408. 2010. View Article : Google Scholar